Benzinga | Oct 29, 2020 04:00PM EDT

Lantern Pharma Q3 EPS $(0.27) Beats $(0.33) Estimate

Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.33) by 18.18 percent.